DeSimone Jill 4

4 · Praxis Precision Medicines, Inc. · Filed Jun 12, 2026

AI-generated summary of this filing

Updated Jun 12, 2026

Praxis (PRAX) Director Jill DeSimone Receives 2,019-Share Award

What Happened

Jill DeSimone, a director of Praxis Precision Medicines (PRAX), received equity awards on 2026-06-10: 1,371 restricted stock units (RSUs) and 648 derivative units, for a total potential 2,019 shares. Both grants were reported as acquisitions at $0 (they are awards, not purchases).

Key Details

Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (timely filing).
Price: $0.00 (awards/grants — no cash exchanged at grant).
Vesting:
- 1,371 RSUs vest in a single installment on the earlier of June 10, 2027 or the date of the 2027 annual meeting; settlement only in common stock (per footnote).
- 648-unit derivative award vests in 12 equal monthly installments on the 10th of each month starting July 10, 2026 and ending on the earlier of June 10, 2027 or the 2027 annual meeting (per footnote).
Shares owned after the transaction: not disclosed in this filing.
Filing accession: 0001689548-26-000061; Period of Report: 2026-06-10.

Context

These are compensation awards (RSUs/derivative units) that convert to actual shares only as they vest; they are common director compensation and do not represent an open‑market purchase or sale.
Because the awards were granted (not sold or bought), they are not a direct bullish or bearish trading signal by themselves.

Form 4

Period: 2026-06-10

Director

Transactions

Award
Common Stock
[F1]
2026-06-10+1,371→ 2,337 total
Award
Stock Option (Right to Buy)
[F2]
2026-06-10+648→ 648 total
Exercise: $240.66Exp: 2036-06-10→ Common Stock (648 underlying)

Footnotes (2)

[F1]Ms. DeSimone was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
[F2]The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Signature

/s/ Alex Nemiroff, as Attorney-in-Fact|2026-06-12

1 file